Search results
Results from the WOW.Com Content Network
All listed chemicals [5] as specified in 21 CFR 1310.02 (a) or (b). This includes supplements which contain a listed chemical, regardless of their dosage form or packaging and regardless of whether the chemical mixture, drug product or dietary supplement is exempt from regulatory controls. For each chemical, its illicit manufacturing use is ...
DEA Office of Diversion Control WWW site, retrieved 26. April 2014; German-language text of Österreichische Suchtmittelgesetz, retrieved 3. May 2014 § 27; German-language text of Deutsche Betäungsmittelgesetz, retrieved 2. May 2014; Innerhalb Betäubungsmittel, IV. Auflage (Wien, 8.
"Chemical Diversion Control Program". Office of Diversion Control - Drug Enforcement Administration. U.S. Department of Justice. Archived from the original on 2018-12-21 "Drug Control:Implementation of the Chemical Diversion and Trafficking Act of 1988" (PDF). U.S. GAO ~ GGD-91-56BR. U.S. Government Accountability Office.
A DEA number (DEA Registration Number) is an identifier assigned to a health care provider (such as a physician, physician assistant, nurse practitioner, optometrist, podiatrist, dentist, or veterinarian) by the United States Drug Enforcement Administration allowing them to write prescriptions for controlled substances.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit [3] [note 1] N/A Not more than 100 milligrams of opium per 100 milliliters or per 100 grams [3] [note 1] N/A Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit [4]
Cardinal, alongside McKesson Corporation and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". [9] The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in ...
Diversion Investigator (DI) is the title of a specialist position within the Drug Enforcement Administration (DEA) of the United States Department of Justice. DIs are responsible for addressing the problem of diversion of controlled pharmaceuticals and regulated chemicals from the legitimate channels in which they are manufactured, distributed ...